Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Molecular and Clinical Oncology|March 24, 2015
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapyEriko Takatori, Tadahiro Shoji, Yuki Miura, et al.
Anticancer Research|February 28, 2023
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective StudyMarina Abe, Tadahiro Shoji, Yohei Chiba, et al.
Cancers|November 14, 2023
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, et al.
International Journal of Clinical Oncology|March 16, 2013
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervixEriko Takatori, Tadahiro Shoji, Yasuko Suga, et al.
Anticancer Research|August 30, 2022
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective StudyShunsuke Tatsuki, Tadahiro Shoji, Marina Abe, et al.
Reproductive Medicine and Biology|April 28, 2018
Anti-Mϋllerian hormone and 3D-power Doppler histogram: markers of ovarian function with in vitro fertilization treatmentMasatoshi Murai, Eriko Takatori, Hideo Omi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2014
Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancerTadahiro Shoji, Eriko Takatori, Yuki Miura, et al.
International Journal of Clinical Oncology|January 4, 2025
Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patientsRikako Ito, Masahiro Kagabu, Sho Sato, et al.
Oncology Letters|September 12, 2012
Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancerTadahiro Shoji, Eriko Takatori, Shinya Hatayama, et al.
Healthcare (Basel, Switzerland)|September 25, 2019
A New Therapeutic Strategy for Recurrent Ovarian Cancer-Bevacizumab beyond Progressive DiseaseTadahiro Shoji, Hisashi Eto, Takanori Sato, et al.
Pageof 5